Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cadieux PA et al. - Antibiotic use with control stents resulted in bacterial antibiotic resistance, which was not the case with the triclosan-eluting stents. Although triclosan-eluting stents did not show a clinical benefit in terms of urine and stent cultures or overall subject symptoms compared with controls, their use did result in decreased antibiotic usage and significantly fewer symptomatic infections. The triclosan-eluting stent alone is not sufficient to reduce device-associated infections in this difficult patient population.

Today in Antimicrobials...keeping you current

Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09

Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults
Antimicrobial Agents and Chemotherapy, 12/07/09

Comparison between concentrations of amphotericin B in infected lung lesion and in uninfected lung tissue in a patient treated with liposomal amphotericin B
International Journal of Infectious Diseases, 12/04/09